Kenvue
- Market cap
- 33.67B
- P/E (TTM)i
- 20.62
- P/Bi
- 3.19
- EPSi
- 0.76
- Div yieldi
- 4.73%
- 52W posi
- 67%
Anonymous reader poll. Unscientific, not investment advice.
About Kenvue
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
- Founded
- 2022
- CEO
- Mr. Kirk L. Perry
- Employees
- 22,000
- Headquarters
- Summit, New Jersey, United States of America
- Fiscal year end
- 01-03
- Website
- kenvue.com
Company profile
- Exchange
- US
- Symbol
- KVUE
- Market-cap rank
- #615
- Listing date
- 2023-05-04
- Market cap
- 33.67B
- Float cap
- 33.62B
- Shares out
- 1.92B
- Float shares
- 1.92B
Sectors & themes
Quote time 2026-10-08 04:01:02 · For reference only, not investment advice and not tailored to your situation.